semaglutide approval for mash fda Expands Novo Nordisk's Wegovy to the Fatty Liver Disease GI and Hepatology News CDSCO Clears Wegovy for MASH

A list of GLP-1 medications include: Dulaglutide (Trulicity) Exenatide (Byetta) Exenatide extended-release (Bydureon) Liraglutide (Victoza) Lixisenatide (Adlyxin) Semaglutide injection (Ozempic) Semaglutide tablets (Rybelsus) Tirzepatide (Mounjaro and Zepbound)* What are the potential health risks and side effects of GLP-1 class of medications

While this can support fat loss goals, it also creates a risk: Undereating key nutrients This is where diet becomes critical

Semaglutide was designed to provide a longer-lasting effect, enhancing patient adherence and outcomes

Simultaneously, semaglutide suppresses inappropriate glucagon secretion from pancreatic alpha cells, which would otherwise raise blood glucose levels